Clinical Trials in San Antonio

Showing 9421-9440 of 14,633 trials

Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)

NCT02393417

This is a placebo-controlled, double-blind (subject, Investigator, and site staff with the exception of unblinded dedicated staff to handle study medication), phase 2a study with 3 dose cohorts, randomized (concealed) to CANDIN or placebo (3:1). Main study will be up to 20 weeks (10 doses administered every other week) or until a subject has complete resolution of all injectable common warts. Subjects who cannot tolerate dosing every 2 weeks due to a local tolerance issue may be injected at 3-week intervals for up to 10 doses, increasing the length of the study to 29 weeks. Subjects will be followed for 4 months after final injection(s) for evidence of new or reoccurring warts and for safety evaluation.

Warts

Nielsen BioSciences, Inc.243 participantsStarted Mar 2015

Fort Smith, Arkansas, United States • Rogers, Arkansas, United States • Encinitas, California, United States +12 more locations

COMPLETEDPhase 2< 1 mile

Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure

NCT02057575

To evaluate the ocular hypotensive efficacy of PG324 ophthalmic solution relative to its individual components in patients with open angle glaucoma or ocular hypertension.

Open Angle GlaucomaOcular Hypertension

Aerie Pharmaceuticals298 participantsStarted Jan 2014

Artesia, California, United States • Inglewood, California, United States • Newport Beach, California, United States +20 more locations

Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)

Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure

Find Trials by Condition in San Antonio

BKM120 as Second-line Therapy for Advanced Endometrial Cancer

Drug-drug Interaction Study of Ozanimod With Pseudoephedrine to Evaluate the Effect on Blood Pressure and Heart Rate

A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis

The Plecanatide Chronic Idiopathic Constipation (CIC) Study

12-Week Study of Plecanatide for CIC (The National CIC3 Study)

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

Validation of Brain Function Assessment Algorithm for mTBI/Concussion in College Athletes

SILVER-AMI: Outcomes in Older Persons With Heart Attacks

Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma

Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

A Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With Osteoporosis

SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.

Randomized Safety Study of CVT-301 Compared to an Observational Control Group

Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer

Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients

A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD)